期刊
RSC ADVANCES
卷 10, 期 52, 页码 31377-31384出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0ra06405j
关键词
-
资金
- National Natural Science Foundation [81874291]
- Sichuan Science and Technology Program [2018HH0100]
- Outstanding Interdiscipline Project of West China Hospital of Sichuan University [ZYJC18024]
beta-Lactam antibiotic resistance mediated by metallo-beta-lactamases (MBL) has threatened global public health. There are currently no available inhibitors of MBLs for clinical use. We previously reported the ruthenium-catalyzed meta-selective C-H nitration synthesis method, leading to somemeta-mercaptopropanamide substituted aryl tetrazoles as new potent MBL inhibitors. Here, we described the structure-activity relationship ofmeta- andortho-mercaptopropanamide substituted aryl tetrazoles with clinically relevant MBLs. The resulting most potent compound13ashowed IC(50)values of 0.044 mu M, 0.396 mu M and 0.71 mu M against VIM-2, NDM-1 and IMP-1 MBL, respectively. Crystallographic analysis revealed that13achelated to active site zinc ionsviathe thiol group and interacted with the catalytically important residues Asn233 and Tyr67, providing further structural information for the development of thiol based MBL inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据